D'Onofrio Matthew J
SEC insider (Form 3/4/5 filer). CIK 0001578770. Chief Executive Officer at Evoke Pharma Inc (EVOK). 6 reported Form 4/5 transactions since Sep 2024; latest on Dec 17, 2025. Located in SOLANA BEACH, CA.
Companies D'Onofrio Matthew J has filed insider reports for
- Evoke Pharma Inc (EVOK): Director, Officer, Chief Executive Officer
D'Onofrio Matthew J
CIK: 0001578770
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Evoke Pharma Inc
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Dec 17, 2025EVOK
Evoke Pharma Inc
DispositionDirectStock Option (Right to Buy)
64.8K shares- - Dec 17, 2025EVOK
Evoke Pharma Inc
DispositionDirectStock Option (Right to Buy)
70K shares- - Dec 16, 2025EVOK
Evoke Pharma Inc
Tender OfferDirect15.5K shares- - Mar 21, 2025EVOK
Evoke Pharma Inc
AwardDirect1K shares at avg. $2.80$3K - Feb 28, 2025EVOK
Evoke Pharma Inc
AwardDirect6.8K shares at avg. $3.65$25K - Jan 28, 2025EVOK
Evoke Pharma Inc
AwardDirectStock Option (Right to Buy)
70K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 17, 2025 | EVOK Evoke Pharma Inc | Disposition Stock Option (Right to Buy) | 64,840 | - | - | Direct |
| Dec 17, 2025 | EVOK Evoke Pharma Inc | Disposition Stock Option (Right to Buy) | 70,000 | - | - | Direct |
| Dec 16, 2025 | EVOK Evoke Pharma Inc | Tender Offer | 15,509 | - | - | Direct |
| Mar 21, 2025 | EVOK Evoke Pharma Inc | Award | 1,000 | $2.80 | $2,797 | Direct |
| Feb 28, 2025 | EVOK Evoke Pharma Inc | Award | 6,849 | $3.65 | $24,999 | Direct |
| Jan 28, 2025 | EVOK Evoke Pharma Inc | Award Stock Option (Right to Buy) | 70,000 | - | - | Direct |
1-6 of 6 transactions